Effect of Serelys Homme on the Incidence and Severity of Vasomotor Symptoms and Quality-of-Life Impairments in Patients Receiving Hormone Therapy and Radiation for Localized Prostate Cancer: Results of the ESCULAPE Phase 2 Prospective Study.

Yazid Belkacemi,Gabriele Coraggio, Anne Brunel,Annie Jouhaud,Alexandre Ingels,Charlotte Joly,Asma Hadhri,Wissal Hassani,Gokoulakrichenane Loganadane,Carolina Saldana,Nabila Ouidir,Barbara Vega,Kamel Debbi,Alexandre de La Taille

Advances in radiation oncology（2023）

引用 0|浏览14

暂无评分

摘要

This study demonstrated effectiveness and excellent tolerance of Serelys Homme. We observed a significant reduction of the frequency, duration, and intensity of hot flushes and sweats induced by ADT. Serelys Homme increased QoL scores. These encouraging results open the prospect to further studies and Serelys Homme use in patients undergoing ADT for prostate cancer.

查看译文

关键词

prostate cancer,vasomotor symptoms,hormone therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要